|
|
|
| Clinical effect of Wenyang huashi zhuyu decoction for treating the chronic pelvic pain of the cold and damp stasis type of patients caused by the sequelae of their pelvic inflammatory disease |
| Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, 610075 |
|
|
|
|
Abstract To investigate the clinical efficacy and safety of Wenyang huashi zhuyu decoction for treating the chronic pelvic pain (CPP) of the cold and damp stasis type of patients caused by the sequelae of pelvic inflammatory disease (SPID). Methods: 64 patients with the cold and damp stasis type CPP caused by SPID were divided into two groups (32 patients in each group) randomly. The patients in the observation group were treated with Wenyang huashi zhuyu decoction, while the patients in the control group were treated with Guizhi poria capsule. The scores of visual analogue scale (VAS) and the traditional Chinese medicine (TCM) syndrome, and the change of the pelvic sign score of the patients after treatment were compared between the two groups. Results: The total effective rate (96.9%) of the patients in the observation group in 12 weeks after treatment was significantly higher than that (75.0%) of the patients in the control group (χ2=16.74, P<0.05). The scores of VAS, TCM syndrome and pelvic signs of the patients in the two groups at each time point after treatment had decreased significantly, and the decrease degree of the VAS score at each time point (1.46±1.62 points, 2.50±1.62 points and 3.34±1.80 points) of the patients in the observation group were significantly more than those (0.65±0.65 points, 1.31±0.86 points and 1.68±1.02 points) of the patients in the control group. At the same time, the improvement of the scores of TCM syndromes and pelvic signs of the patients in the observation group were significantly better than those of the patients in the control group (P<0.05). Conclusion: The Wenyang huashi zhuyu decoction for treating the cold and damp stasis type CPP of the patients caused by SPID has the definite clinical efficacy, which can alleviate the pain symptoms and pelvic signs of the patients, and with good safety.
|
|
|
|
|
|
|
|
|
